BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 27853186)

  • 21. Fatty liver creates a pro-metastatic microenvironment for hepatocellular carcinoma through activation of hepatic stellate cells.
    Mikuriya Y; Tashiro H; Kuroda S; Nambu J; Kobayashi T; Amano H; Tanaka Y; Ohdan H
    Int J Cancer; 2015 Feb; 136(4):E3-13. PubMed ID: 25053237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. GSK-3β regulates the endothelial-to-mesenchymal transition via reciprocal crosstalk between NSCLC cells and HUVECs in multicellular tumor spheroid models.
    Kim SH; Song Y; Seo HR
    J Exp Clin Cancer Res; 2019 Feb; 38(1):46. PubMed ID: 30709379
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma.
    Yu G; Jing Y; Kou X; Ye F; Gao L; Fan Q; Yang Y; Zhao Q; Li R; Wu M; Wei L
    PLoS One; 2013; 8(9):e73312. PubMed ID: 24023859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells.
    Nagahara T; Shiraha H; Sawahara H; Uchida D; Takeuchi Y; Iwamuro M; Kataoka J; Horiguchi S; Kuwaki T; Onishi H; Nakamura S; Takaki A; Nouso K; Yamamoto K
    Oncol Rep; 2015 Sep; 34(3):1169-77. PubMed ID: 26165819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma.
    Ji J; Eggert T; Budhu A; Forgues M; Takai A; Dang H; Ye Q; Lee JS; Kim JH; Greten TF; Wang XW
    Hepatology; 2015 Aug; 62(2):481-95. PubMed ID: 25833323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway.
    Zhang R; Gao X; Zuo J; Hu B; Yang J; Zhao J; Chen J
    Cancer Sci; 2020 Feb; 111(2):406-417. PubMed ID: 31785057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX; Liao R; Pan L; Du CY
    Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interleukin-17A educated hepatic stellate cells promote hepatocellular carcinoma occurrence through fibroblast activation protein expression.
    Ni JS; Fu SY; Wang ZY; Ding WB; Huang J; Guo XG; Gu FM
    J Gene Med; 2024 Jun; 26(6):e3693. PubMed ID: 38860366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newcastle disease virus represses the activation of human hepatic stellate cells and reverses the development of hepatic fibrosis in mice.
    Li YL; Wu J; Wei D; Zhang DW; Feng H; Chen ZN; Bian H
    Liver Int; 2009 Apr; 29(4):593-602. PubMed ID: 19192169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activated hepatic stellate cells promote hepatocellular carcinoma development in immunocompetent mice.
    Zhao W; Zhang L; Yin Z; Su W; Ren G; Zhou C; You J; Fan J; Wang X
    Int J Cancer; 2011 Dec; 129(11):2651-61. PubMed ID: 21213212
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cirrhotic stiffness affects the migration of hepatocellular carcinoma cells and induces sorafenib resistance through YAP.
    Gao J; Rong Y; Huang Y; Shi P; Wang X; Meng X; Dong J; Wu C
    J Cell Physiol; 2019 Mar; 234(3):2639-2648. PubMed ID: 30145835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma.
    Quiroz Reyes AG; Lozano Sepulveda SA; Martinez-Acuña N; Islas JF; Gonzalez PD; Heredia Torres TG; Perez JR; Garza Treviño EN
    Technol Cancer Res Treat; 2023; 22():15330338231163677. PubMed ID: 36938618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CCN1/Cyr61 enhances the function of hepatic stellate cells in promoting the progression of hepatocellular carcinoma.
    Li ZQ; Wu WR; Zhao C; Zhao C; Zhang XL; Yang Z; Pan J; Si WK
    Int J Mol Med; 2018 Mar; 41(3):1518-1528. PubMed ID: 29286082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
    Tomuleasa C; Soritau O; Rus-Ciuca D; Pop T; Todea D; Mosteanu O; Pintea B; Foris V; Susman S; Kacsó G; Irimie A
    J Gastrointestin Liver Dis; 2010 Mar; 19(1):61-7. PubMed ID: 20361077
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXQ1/NDRG1 axis exacerbates hepatocellular carcinoma initiation via enhancing crosstalk between fibroblasts and tumor cells.
    Luo Q; Wang CQ; Yang LY; Gao XM; Sun HT; Zhang Y; Zhang KL; Zhu Y; Zheng Y; Sheng YY; Lu L; Jia HL; Yu WQ; Liu J; Dong QZ; Qin LX
    Cancer Lett; 2018 Mar; 417():21-34. PubMed ID: 29248714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deciphering the possible reciprocal loop between hepatic stellate cells and cancer cells in the tumor microenvironment of the liver.
    Ezhilarasan D; Najimi M
    Crit Rev Oncol Hematol; 2023 Feb; 182():103902. PubMed ID: 36621514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression.
    Hsieh SC; Tsai JP; Yang SF; Tang MJ; Hsieh YH
    Amino Acids; 2014 Dec; 46(12):2809-22. PubMed ID: 25245054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracellular vesicles-derived OncomiRs mediate communication between cancer cells and cancer-associated hepatic stellate cells in hepatocellular carcinoma microenvironment.
    Li J; Yan Y; Ang L; Li X; Liu C; Sun B; Lin X; Peng Z; Zhang X; Zhang Q; Wu H; Zhao M; Su C
    Carcinogenesis; 2020 Apr; 41(2):223-234. PubMed ID: 31140556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression.
    Wang Q; Yu W; Huang T; Zhu Y; Huang C
    Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β1 integrin-mediated multicellular resistance in hepatocellular carcinoma through activation of the FAK/Akt pathway.
    Tian T; Li CL; Fu X; Wang SH; Lu J; Guo H; Yao Y; Nan KJ; Yang YJ
    J Int Med Res; 2018 Apr; 46(4):1311-1325. PubMed ID: 29332411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.